Recruiting Pulmonary Embolism Studies in Columbia
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
PRECIDENTD is a randomized, open label, pragmatic clinical trial designed to compare rates of the total number of cardiovascular, kidney, and death events among two alternative treatments for patients...
Safety and Efficacy of FT218 in Idiopathic Hypersomnia (REVITALYZ)
This is a double-blind, placebo-controlled, randomized withdrawal, multicenter study of the efficacy and safety of FT218. FT218 drug product is a once-nightly formulation of sodium oxybate for extende...
Study to Assess the Efficacy and Safety of Iovera®° System in Subjects With Upper Extremity Spasticity
This multicenter, randomized, double-blind, sham-controlled study is designed to evaluate the efficacy and safety of the iovera° system in subjects with upper extremity spasticity. A total of approxim...
CardiolRx in Recurrent Pericarditis Following IL-1 Blocker Cessation
Multi-center, randomized, double-blind, placebo-controlled, phase-3 Trial. Patients with a history of recurrent pericarditis who are being treated with an IL-1 blocker for at least 12 months, schedule...
Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent
This Phase 2 clinical trial will study RVP-001, a new manganese-based MRI contrast agent, in people who are known to have gadolinium-enhancing central nervous system (CNS) lesions, for example brain t...
About Pulmonary Embolism Clinical Trials in Columbia
Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.
There are currently 5 pulmonary embolism clinical trials recruiting participants in Columbia, MD. These studies are seeking a combined 6,416 participants. Research is being sponsored by Brigham and Women's Hospital, Avadel, Pacira Pharmaceuticals, Inc and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Embolism Clinical Trials in Columbia — FAQ
Are there pulmonary embolism clinical trials in Columbia?
Yes, there are 5 pulmonary embolism clinical trials currently recruiting in Columbia, MD. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Columbia?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Columbia research site will contact you about next steps.
Are clinical trials in Columbia free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Columbia studies also compensate for your time and travel.
What pulmonary embolism treatments are being tested?
The 5 active trials in Columbia are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.
Data updated March 2, 2026 from ClinicalTrials.gov